Developing Canada’s vaccine infrastructure for future pandemics will depend on addressing bio-economy labour shortages

Provided the key players—government, business and academia—work closely together, there’s no reason why we can’t regain our vaccine independence and re-establish our leadership role in vaccine production.

The challenges of developing made-in-Canada vaccines may sound daunting, but Canada has done it before. We have a strong track record of innovation and vaccine development, including helping bring the polio vaccine to the world in the 1950s, writes Rob Henderson. Image courtesy of Pixabay

Opinion

BY ROB HENDERSON

September 13, 2021

After having to depend exclusively on international partners for COVID-19 vaccines, it’s encouraging to see Canada investing heavily in infrastructure projects to build our vaccine independence for future pandemics. Canada has been fortunate to secure significant COVID-19 vaccine supplies from ot...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy